ArticleMolecular neurobiology2025
SIRT3/AMPK-Driven Mitophagy Failure Underlies Methylmercury-Induced Neurotoxicity: Evidence from Humans to Cells.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Kaempferol alleviates T-cell immunosenescence and inflammaging in aged mice via the SIRT3-LKB1-AMPK-mitophagy pathway.Immunity & ageing : I & A · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Methylmercury (MeHg) is a global environmental pollutant notorious for its developmental neurotoxicity. Although many mechanisms of MeHg toxicity have been proposed, the precise molecular pathways remain incompletely understood. This study integrated population and cell models and utilized high-throughput transcriptomic screening of umbilical cord blood (UCB) and neuronal samples to identify differentially expressed genes associated with MeHg exposure. Subsequently, in vitro validation of the key mechanisms was performed. Omics data showed that differentially expressed genes in UCB from MeHg exposure are linked to mitophagy. Additionally, transcriptome sequencing of primary hippocampal neurons revealed the potential effects of MeHg on energy metabolism, indicating a mitochondrial mechanism that requires further investigation. Further in vitro mechanistic studies revealed that SIRT3/AMPK, key mediators of PINK1-dependent mitophagy, were activated by MeHg exposure. Notably, when PC12 cells were exposed to MeHg, SIRT3 was upregulated compensatorily. Our findings support a model in which MeHg-induced SIRT3 upregulation facilitates AMPKα (Thr172) phosphorylation via LKB1, suggesting that this pathway is associated with mitophagy activation, as evidenced by increased Beclin1 expression, LC3II/I conversion, and decreased p62 levels. Mitophagy was initiated as a defense response to remove damaged mitochondria and exogenous toxicants. Nevertheless, such successive cellular responses exacerbated mitochondrial stress, resulting in neuronal damage and synaptic underfeeding. Together, these results offer novel mechanistic insights into how SIRT3/AMPK-mediated mitophagy coordination regulates MeHg-induced neurotoxicity, providing potential therapeutic targets for developmental neurological disorders.
Indexed as
Identifiers
41390580What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.